4//SEC Filing
KYTHERA BIOPHARMACEUTICALS INC 4
Accession 0001179110-14-001911
CIK 0001436304operating
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 7:12 PM ET
Size
10.7 KB
Accession
0001179110-14-001911
Insider Transaction Report
Form 4
Webster Jeffrey D
Senior VP, Operations
Transactions
- Sale
Common Stock
2014-02-03$45.90/sh−1,800$82,620→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2014-02-03−4,000→ 50,761 totalExercise: $0.76Exp: 2017-03-13→ Common Stock (4,000 underlying) - Sale
Common Stock
2014-02-03$45.00/sh−2,200$98,998→ 1,800 total - Exercise/Conversion
Common Stock
2014-02-03$0.76/sh+4,000$3,040→ 4,000 total
Footnotes (4)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires April 30, 2014.
- [F2]100% of the shares subject to the option are fully vested and exercisable.
- [F3]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $44.57 to $45.50, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $45.515 to $46.33, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
KYTHERA BIOPHARMACEUTICALS INC
CIK 0001436304
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001436304
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 7:12 PM ET
- Size
- 10.7 KB